FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely gastroenterology, and may be used for treating inflammatory intestinal diseases. That is ensured by the preliminary oral administration of the probiotic Bifiform 2-3 capsules a day that is followed by the 4-5 mucosal introductions of the preparation 0.5 to 1.5 ml in the changed intestinal region; the preparation is presented by Remicade and followed by the intake of the probiotic Bifiform 1 capsule 3 times a day for 3 weeks.
EFFECT: method provides higher clinical effectiveness ensured by enhanced epithelial cell proliferation and improved formation of small follicles and expansion in goblet cell count in intestinal mucosa, normalisation of intestinal crypt structure.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ULCERATIVE COLITIS AND CROHN'S DISEASE THERAPY | 2011 |
|
RU2460554C1 |
METHOD OF TREATING SECONDARY LACTASE DEFICIENCY | 2011 |
|
RU2477633C2 |
METHOD OF EVALUATING EFFICIENCY OF CROHN'S DISEASE AND ULCERATIVE COLITIS TREATMENT | 2008 |
|
RU2391914C2 |
DIAGNOSTIC TECHNIQUE FOR BRONCHIAL OBSTRUCTION ACCOMPANYING INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2451488C1 |
METHOD OF ASSESSING CLINICAL EFFECTIVENESS IN INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2477478C1 |
THERAPY OF INFLAMMATORY BOWEL DISEASES | 2008 |
|
RU2364405C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE IN CONSTIPATIONS | 2011 |
|
RU2474381C1 |
DIAGNOSTIC TECHNIQUE FOR CHOLAGENIC DIARRHOEA | 2011 |
|
RU2475182C1 |
METHOD OF TREATING ULCERATIVE PROCTOSIGMOIDITIS | 2008 |
|
RU2367450C1 |
METHOD FOR EVALUATING CLINICAL EFFECTIVENESS OF MESENCHYMAL STROMAL CELLS FOR INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2463596C1 |
Authors
Dates
2012-10-10—Published
2011-01-12—Filed